These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31140698)

  • 21. [Proliferating cell nuclear antigen (PCNA) in oral leukoplakia].
    Qiao B; Yu S; Pang S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Jul; 30(4):210-1. PubMed ID: 8745441
    [No Abstract]   [Full Text] [Related]  

  • 22. [Review of the literature on the possibility of malignant transformation of oral leukoplakia].
    Tartaro S; Colella G; Cuomo E; Giudice M
    Stomatol Mediterr; 1986; 6(3):313-24. PubMed ID: 3538441
    [No Abstract]   [Full Text] [Related]  

  • 23. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia.
    Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E
    Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program.
    Chuang SL; Wang CP; Chen MK; Su WW; Su CW; Chen SL; Chiu SY; Fann JC; Yen AM
    Oral Oncol; 2018 Dec; 87():58-63. PubMed ID: 30527244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Proteomic Biomarkers in Proliferative Verrucous Leukoplakia through Liquid Chromatography With Tandem Mass Spectrometry.
    Arroyo E; Pérez Sayáns M; Bravo SB; de Oliveira Barbeiro C; Paravani Palaçon M; Chamorro Petronacci CM; García Vence M; Chantada Vázquez MDP; Blanco Carrión A; Suárez Peñaranda JM; García García A; Gándara Vila P; Días Almeida J; Veríssimo da Costa GC; Sousa Nogueira FC; Medeiros Evaristo JA; de Abreu Pereira D; Rintala M; Salo T; Rautava J; Padín Iruegas E; Oliveira Alves MG; Morandin Ferrisse T; Albergoni da Silveira H; Esquiche León J; Vilela Silva E; Flores IL; Bufalino A
    Lab Invest; 2023 Oct; 103(10):100222. PubMed ID: 37507024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The malignant transformation of leukoplakia of the oral cavity. A review of the literature and clinical case reports].
    Colella G; De Luca F; Lanza A; Tartaro GP
    Minerva Stomatol; 1995 Jun; 44(6):291-300. PubMed ID: 7476784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between p62 expression and clinicopathological characteristics in oral leukoplakia.
    Yoshida T; Terabe T; Nagai H; Uchida F; Hasegawa S; Nagao T; Miyabe S; Ishibashi-Kanno N; Yamagata K; Warabi E; Gosho M; Yanagawa T; Bukawa H
    Clin Exp Dent Res; 2019 Aug; 5(4):389-397. PubMed ID: 31452949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
    Schepman KP; van der Meij EH; Smeele LE; van der Waal I
    Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pathogenesis of proliferative verrucous leukoplakia: a systematic review.
    Okoturo EM; Risk JM; Schache AG; Shaw RJ; Boyd MT
    Br J Oral Maxillofac Surg; 2018 Nov; 56(9):780-785. PubMed ID: 30190088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical manifestations of oral proliferative verrucous leukoplakia: A systematic review.
    Torrejon-Moya A; Jané-Salas E; López-López J
    J Oral Pathol Med; 2020 May; 49(5):404-408. PubMed ID: 31990082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs and their role in the malignant transformation of oral leukoplakia: a scoping review.
    Niklander S; Guerra D; Contreras F; González-Arriagada W; Marín C
    Med Oral Patol Oral Cir Bucal; 2022 Jan; 27(1):e77-e84. PubMed ID: 34564679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. World Workshop on Oral Medicine VII: Targeting the oral microbiome Part 2: Current knowledge on malignant and potentially malignant oral disorders.
    Robledo-Sierra J; Ben-Amy DP; Varoni E; Bavarian R; Simonsen JL; Paster BJ; Wade WG; Kerr R; Peterson DE; Frandsen Lau E
    Oral Dis; 2019 Jun; 25 Suppl 1():28-48. PubMed ID: 31140694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.
    Dong Y; Chen Y; Tao Y; Hao Y; Jiang L; Dan H; Zeng X; Chen Q; Zhou Y
    Lasers Med Sci; 2019 Feb; 34(1):209-221. PubMed ID: 30443884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
    Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
    Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Abnormalities in Oral Leukoplakia and Oral Cancer Progression.
    Kil TJ; Kim HS; Kim HJ; Nam W; Cha IH
    Asian Pac J Cancer Prev; 2016; 17(6):3001-6. PubMed ID: 27356725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant transformation of leukoplakia.
    McCartan B
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Apr; 85(4):348-9. PubMed ID: 9574937
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of Malignant Transformation of Oral Leukoplakia and Oral Lichen Planus Using Laser: An Observational Study.
    Arora KS; Bansal R; Mohapatra S; Verma A; Sharma S; Pareek S
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3635-3641. PubMed ID: 30583693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
    Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentially Malignant Oral Disorders and Cancer Transformation.
    Ganesh D; Sreenivasan P; Öhman J; Wallström M; Braz-Silva PH; Giglio D; Kjeller G; Hasséus B
    Anticancer Res; 2018 Jun; 38(6):3223-3229. PubMed ID: 29848669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.